DCOY is trading at $8.55 (down 10.8%) as the stock undergoes a period of normalization following a massive triple-digit surge earlier in the session.
- Decoy Therapeutics shares jumped over 140% on June 29, 2026, after announcing a $3.5 million private placement to fund clinical trials.
- The financing includes milestone-based warrants, providing a strategic capital infusion for the company's therapeutic pipeline.
- The current pullback likely reflects profit-taking and market stabilization following the outsized rally triggered by the funding news.